Dr. Minghui Wei 魏明辉
Chief Physician
Department of Head and Neck Surgery, Cancer Hospital, Chinese Academy of Medical Sciences, Shenzhen Center, Shenzhen
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and surgical treatment of thyroid, laryngeal, hypopharyngeal, parotid, and oral/maxillofacial tumors. Expertise includes endoscopic nasopharyngeal/nasal sinus tumor resection, lateral skull base tumor resection, laryngeal microsurgical laser surgery, and head and neck reconstruction.
Dr. Wei holds an MD (1990), Master’s in Otolaryngology (1996), and PhD in Oncology (2009). Trained at Université Libre de Bruxelles and MD Anderson Cancer Center. With 30 years in clinical practice, teaching, and research, Dr. Wei has led three Shenzhen research projects, published over 30 papers, and co-authored two monographs.
Professional roles
- Chair, Head and Neck Oncology Professional Committee, Shenzhen Anti-Cancer Association
- Vice Chair, Otolaryngology-Head and Neck Surgery Professional Committee, Shenzhen Medical Association
- Vice Chair, Thyroid and Breast Surgery Professional Committee, Shenzhen Medical Association
- Editorial Board Member, Chinese Medical Digest: Otorhinolaryngology
Name order: in Chinese the family name comes first (Wei Minghui). Papers usually list the name as Minghui Wei or Wei M.
Selected publications
25 papers on PubMed matched by name and affiliation; 5 as first or senior author since 2016. Most recent first- or senior-author papers:
- Clin Case Rep, 2026 (senior author): Surgical Challenges in Papillary Thyroid Cancer Patient With Kartagener's Syndrome: A Case Report. PubMed 42022982
- Am J Cancer Res, 2025 (senior author): Efficacy and toxicity of PD-1 inhibitor combined with induction chemotherapy for locally advanced laryngeal and hypopharyngeal cancers. PubMed 40520879
- Cell Mol Biol (Noisy-le-grand), 2022 (senior author): Mechanism of Astrin in Head and Neck Squamous Cell Carcinoma. PubMed 36495506
- Clin Immunol, 2022 (senior author): Cancer germline antigen gene MAGEB2 promotes cell invasion and correlates with immune microenvironment and immunotherapeutic efficiency in laryngeal cancer. PubMed 35618211
- J Anat, 2019 (senior author): Visualisation of the vomerovaginal canal during endonasal transpterygoid approaches and CT imaging diagnosis. PubMed 31318052
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion